CD25-bindende Moleküle
Patent europeic · EP0449769 · Stritgà
Inscripziun en il register
- Numer da publicaziun
- EP0449769
- Numer da la dumonda
- EP91810166
- Gener
- Patent europeic cun effect per la Svizra ed il Liechtenstein
- Status
- Stritgà
- Scrittira da patent
- Concedì
- Annunzià
- 13-03-1991
- Publitgà
- 02-10-1991
- Concedì
- 15-12-1993
- Stritgà
- 12-03-2011
- Motiv
- Durada maximala cuntanschida
- Classas IPC
- C07K 15/28 (1990.01)C12N 15/13 (2006.01)C12P 21/08 (2006.01)A61K 39/395 (2006.01)
- Prioritad
- GB A 9005962 16.03.1990GB A 9019323 05.09.1990
- Lingua da l’annunzia
- englais
- Funtauna
- Swissreg
Certificats cumplementars da protecziun
In certificat prolunghescha la protecziun dal patent per in medicament u in product da protecziun da plantas admess en Svizra.
Istorgia
Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.
- 14-03-2011
Durada maximala cuntanschida
Published in Swissreg on 14.03.2011
- 15-05-1997
Adressa midada
- Owner
- Sandoz AG, Lichtstrasse 35, 4002 Basel, Royal Free Hospital School of, Medicine, Rowland Hill Street, London NW3, United Kingdom → Royal Free Hospital School of, Medicine, Rowland Hill Street, London NW3, United Kingdom, Novartis AG, Schwarzwaldallee 215, 4058 Basel
Published in PIDTJ No 9 in 1997
- 31-01-1994
Concedì
Published in PIDTJ No 2 in 1994
Partidas
Possessur
Represchentant
Inventur
London N9 9BL, GB
Richmond, Surrey TW94LD, GB
CH-4125 Riehen
CH-4153 Reinach
Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.